Discusses CEO Transition and Management Continuity Strategy Following Code of Conduct Investigation December 8, 2025 7:00 ...

Investing.com -- Carl Zeiss Meditec announced that CEO Maximilian Foerst will step down on December 31 following a violation of the company’s internal Code of Conduct. Shares are down 0.5% today.

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Carl Zeiss Meditec AG (ETR:AFX) is about to go ex-dividend ...

Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment JENA, Germany, Dec. 15, 2023 /PRNewswire/ -- Carl ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

A look at the shareholders of Carl Zeiss Meditec AG (ETR:AFX) can tell us which group is most powerful. The group holding the most number of shares in the company, around 59% to be precise, is private ...

Fintel reports that on August 5, 2024, METZLER EQUITIES upgraded their outlook for Carl Zeiss Meditec AG - Depositary Receipt () (OTCPK:CZMWY) from Hold to Buy. As of August 6, 2024, the average ...

Please provide your email address to receive an email when new articles are posted on . The stolen Zeiss files acquired by Topcon included highly confidential information. Topcon has agreed to pay a ...

ZEISS secures regulatory approvals to acquire D.O.R.C.; companies now shift focus to integration implementation, fueling world-class innovation, and driving market expansion strategy for ophthalmic ...

Carl Zeiss Meditec AG Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective ...

Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment D.O.R.C., a leading player in the retinal surgical ...

As of 8:10:03 am GMT+1. Market open. ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology ...